Advertisement
Advertisement
EDSA
Edesa Biotech, Inc. Common Shares
4.03
USDSponsored
+0.06
+1.51%
Sep 24, 15:59 UTC -4
Closed
After-Market
4.08
+0.05
+1.36%
EDSA Earnings Reports
Positive Surprise Ratio
EDSA beat 20 of 32 last estimates.
63%
Next Report
Date of Next Report
Dec 10, 2026
Estimate for Q4 26 (Revenue/ EPS)
--
/-$0.59
Implied change from Q3 26 (Revenue/ EPS)
--
/-1.67%
Implied change from Q4 25 (Revenue/ EPS)
--
/+84.37%
Edesa Biotech, Inc. Common Shares earnings per share and revenue
On Aug 13, 2026, EDSA reported earnings of -0.60 USD per share (EPS) for Q3 26, missing the estimate of -0.59 USD, resulting in a -1.42% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -1.47% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 4 analysts forecast an EPS of -0.59 USD, with revenue projected to reach -- USD, implying an decrease of -1.67% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AYTU BioPharma, Inc. Common Stock
Report Date
Sep 22, 2026 For Q4 26
Estimate
-$0.33
Actual
-$0.05
Surprise
+84.92%
Neuphoria Therapeutics Inc. Common Stock
Report Date
Sep 18, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.95
Surprise
-66.32%
NewcelX Ltd. Ordinary Shares
Report Date
Sep 18, 2026 For Q2 26
Estimate
-$0.54
Actual
-$0.96
Surprise
-77.58%
Abivax SA - ADR
Report Date
Sep 21, 2026 For Q2 26
Estimate
-$1.82
Actual
-$2.09
Surprise
-14.47%
AnaptysBio, Inc. Common Stock
Report Date
Sep 21, 2026 For Q2 26
Estimate
$0.00
Actual
$5.11
Surprise
>+10,000.00%
BlossomHill Therapeutics, Inc. Common Stock
Report Date
Sep 18, 2026 For Q2 26
Estimate
-$1.03
Actual
-$8.75
Surprise
-746.56%
Vogenx Inc Common Stock
Report Date
Sep 17, 2026 For Q2 26
Estimate
-$0.07
Actual
-$0.07
Surprise
+1.96%
Benitec Biopharma Inc. Common Stock
Report Date
Sep 14, 2026 For Q4 26
Estimate
-$0.27
Actual
-$0.26
Surprise
+5.59%
FAQ
What were Edesa Biotech, Inc. Common Shares's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Edesa Biotech, Inc. Common Shares reported EPS of -$0.60, missing estimates by -1.42%, and revenue of $0.00, 0% as expectations.
How did the market react to Edesa Biotech, Inc. Common Shares's Q3 2026 earnings?
The stock price moved down -1.47%, changed from $5.43 before the earnings release to $5.35 the day after.
When is Edesa Biotech, Inc. Common Shares expected to report next?
The next earning report is scheduled for Dec 10, 2026.
What are the forecasts for Edesa Biotech, Inc. Common Shares's next earnings report?
Based on 4
analysts, Edesa Biotech, Inc. Common Shares is expected to report EPS of -$0.59 and revenue of -- for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.